Ariad Pharm Inc (ARIA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2000 | 12-1999 | 12-1998 | 12-1997 | 12-1996 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -13,832 | 24,192 | -26,140 | 0 | -6,176 |
| Depreciation Amortization | 1,675 | 3,682 | 3,460 | 0 | 2,294 |
| Accounts payable and accrued liabilities | -842 | -1,046 | 0 | 0 | 0 |
| Other Working Capital | -3,246 | -3,346 | -4,740 | 0 | -5,642 |
| Other Operating Activity | 1,147 | -45,206 | 80 | 0 | 27 |
| Operating Cash Flow | $-15,098 | $-21,724 | $-27,340 | $0 | $-9,497 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -27,160 | 7,595 | 0 | 0 | 0 |
| PPE Investments | -447 | -677 | -1,670 | 0 | 0 |
| Net Acquisitions | N/A | 41,699 | 0 | 0 | -452 |
| Purchase Sale Intangibles | -1,205 | -710 | 0 | 0 | 0 |
| Other Investing Activity | -1,205 | -710 | 6,440 | 0 | 9,134 |
| Investing Cash Flow | $-28,812 | $47,907 | $4,770 | $0 | $8,682 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 3,000 | 1,801 | 0 | 0 | 0 |
| Debt Repayment | -1,200 | -2,056 | 0 | 0 | 0 |
| Common Stock Issued | 26,333 | 159 | 0 | 0 | 0 |
| Other Financing Activity | 0 | -4,269 | 15,220 | 0 | -28 |
| Financing Cash Flow | $28,133 | $-4,365 | $15,220 | $0 | $-28 |
| Beginning Cash Position | 28,320 | 6,502 | 13,850 | 0 | 3,750 |
| End Cash Position | 12,543 | 28,320 | 6,500 | 0 | 2,907 |
| Net Cash Flow | $-15,777 | $21,818 | $-7,350 | $0 | $-843 |
| Free Cash Flow | |||||
| Operating Cash Flow | -15,098 | -21,724 | -27,340 | 0 | -9,497 |
| Capital Expenditure | -447 | -677 | 0 | 0 | 0 |
| Free Cash Flow | -15,545 | -22,401 | -27,340 | 0 | -9,497 |